Market Overview:
The global transcranial electrical stimulators market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising awareness about the benefits of transcranial electrical stimulation (TES), and technological advancements in TES devices. Based on type, the global transcranial electrical stimulators market is segmented into transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcranial pulsed current stimulation (tPCS), and trans-cranial random noise stimula-tion (tRNS). tDCS is expected to account for the largest share of the global Transcra-nial Electrical Stimulators Market by type during the forecast period. This can be attributed to its growing popularity among patients owing to its noninvasive nature and lack of side effects as compared with other TES devices.
Product Definition:
Transcranial Electrical Stimulators (TES) are devices that use electrical current to stimulate the brain. TES has been used to treat a variety of conditions, including depression, anxiety, and chronic pain. Some research suggests that TES may also be helpful for cognitive enhancement and treating neurological disorders such as Alzheimer's disease and stroke.
Transcranial Direct Current Stimulation (tDCS):
tDCS is an experimental technique that uses a weak electric current directed to the brain through the skull. The current stimulation is observed to alter the neural activities during the performance of simple cognitive tasks. It has been observed that, it enhances or impairs spatial and nonspatial memory, affects attention allocation, improves or hinders executive functions such as planning and working memory; depending on polarity and duration of current injection (1-90 minutes).
Transcranial Alternating Current Stimulation (tACS):
Transcranial alternating current stimulation (tACS) is a non-invasive technique that uses weak electrical currents to modulate brain activity. It has been used in treating depression, neurological disorders, and cognitive problems. The device works by delivering an extremely low frequency of magnetic fields which alternates between two different electrodes placed on the scalp over the brain region responsible for pain or discomfort.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing prevalence of neurological disorders that require treatment with tDCS along with an increase in number of clinical trials using tDCS for brain stimulation. Furthermore, growing awareness among patients and healthcare professionals regarding potential benefits associated with tDCS is also expected to drive growth over the forecast period.
The Clinic segment held a significant share owing to factors such as high usage rates across neurorehabilitation clinics for treating various neurological conditions including stroke and traumatic brain injury (TBI). Moreover, an increase in research collaborations between major players coupled with government initiatives aimed at promoting adoption rate among clinics is further anticipated to boost product demand over the forecast period.
The Others application category includes educational institutions, corporate offices.
Regional Analysis:
North America dominated the global market in 2017. The growth can be attributed to rising government initiatives, increasing awareness about tESC devices, and presence of well-established healthcare facilities in the region. Moreover, growing preference for minimally invasive surgeries is also expected to drive the demand for tESCs in North America over the forecast period. Europe accounted for a significant share of global revenue due to high adoption rate of technologically advanced medical products and solutions along with favorable reimbursement policies pertaining to tESC devices used for clinical purposes.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to untapped opportunities.
Growth Factors:
- Increasing demand for non-invasive brain stimulation therapies to treat various neurological disorders
- Growing number of TES clinical trials for various indications such as depression, Alzheimer's disease, and chronic pain
- Rising prevalence of neurological disorders across the globe
- Technological advancements in TES devices and increasing awareness about its benefits among clinicians and patients
- Growing number of research studies on the use of TES for different applications
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcranial Electrical Stimulators Market Research Report
By Type
Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcranial Pulsed Current Stimulation (tPCS), Transcranial Random Noise Stimulation (tRNS)
By Application
Hospital, Clinic, Others
By Companies
Magstim , NeuroCare Group , Neuroelectrics, Newronika, Rogue Resolutions , Soterix Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Transcranial Electrical Stimulators Market Report Segments:
The global Transcranial Electrical Stimulators market is segmented on the basis of:
Types
Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcranial Pulsed Current Stimulation (tPCS), Transcranial Random Noise Stimulation (tRNS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MagstimÂ
- NeuroCare GroupÂ
- Neuroelectrics
- Newronika
- Rogue ResolutionsÂ
- Soterix Medical
Highlights of The Transcranial Electrical Stimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Alternating Current Stimulation (tACS)
- Transcranial Pulsed Current Stimulation (tPCS)
- Transcranial Random Noise Stimulation (tRNS)
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcranial Electrical Stimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transcranial electrical stimulators (TES) are devices that use an electric current to stimulate the brain. They are used to treat a variety of conditions, including depression, anxiety, and chronic pain. TES can also be used for research purposes.
Some of the key players operating in the transcranial electrical stimulators market are Magstim‚Â , NeuroCare Group‚Â , Neuroelectrics, Newronika, Rogue Resolutions‚Â , Soterix Medical.
The transcranial electrical stimulators market is expected to grow at a compound annual growth rate of 10.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcranial Electrical Stimulators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcranial Electrical Stimulators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcranial Electrical Stimulators Market - Supply Chain
4.5. Global Transcranial Electrical Stimulators Market Forecast
4.5.1. Transcranial Electrical Stimulators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcranial Electrical Stimulators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transcranial Electrical Stimulators Market Absolute $ Opportunity
5. Global Transcranial Electrical Stimulators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transcranial Electrical Stimulators Market Size and Volume Forecast by Type
5.3.1. Transcranial Direct Current Stimulation (tDCS)
5.3.2. Transcranial Alternating Current Stimulation (tACS)
5.3.3. Transcranial Pulsed Current Stimulation (tPCS)
5.3.4. Transcranial Random Noise Stimulation (tRNS)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transcranial Electrical Stimulators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transcranial Electrical Stimulators Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transcranial Electrical Stimulators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transcranial Electrical Stimulators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transcranial Electrical Stimulators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transcranial Electrical Stimulators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transcranial Electrical Stimulators Demand Share Forecast, 2019-2026
9. North America Transcranial Electrical Stimulators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transcranial Electrical Stimulators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transcranial Electrical Stimulators Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transcranial Electrical Stimulators Market Size and Volume Forecast by Type
9.7.1. Transcranial Direct Current Stimulation (tDCS)
9.7.2. Transcranial Alternating Current Stimulation (tACS)
9.7.3. Transcranial Pulsed Current Stimulation (tPCS)
9.7.4. Transcranial Random Noise Stimulation (tRNS)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transcranial Electrical Stimulators Demand Share Forecast, 2019-2026
10. Latin America Transcranial Electrical Stimulators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transcranial Electrical Stimulators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transcranial Electrical Stimulators Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transcranial Electrical Stimulators Market Size and Volume Forecast by Type
10.7.1. Transcranial Direct Current Stimulation (tDCS)
10.7.2. Transcranial Alternating Current Stimulation (tACS)
10.7.3. Transcranial Pulsed Current Stimulation (tPCS)
10.7.4. Transcranial Random Noise Stimulation (tRNS)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transcranial Electrical Stimulators Demand Share Forecast, 2019-2026
11. Europe Transcranial Electrical Stimulators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transcranial Electrical Stimulators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transcranial Electrical Stimulators Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transcranial Electrical Stimulators Market Size and Volume Forecast by Type
11.7.1. Transcranial Direct Current Stimulation (tDCS)
11.7.2. Transcranial Alternating Current Stimulation (tACS)
11.7.3. Transcranial Pulsed Current Stimulation (tPCS)
11.7.4. Transcranial Random Noise Stimulation (tRNS)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transcranial Electrical Stimulators Demand Share, 2019-2026
12. Asia Pacific Transcranial Electrical Stimulators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transcranial Electrical Stimulators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transcranial Electrical Stimulators Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transcranial Electrical Stimulators Market Size and Volume Forecast by Type
12.7.1. Transcranial Direct Current Stimulation (tDCS)
12.7.2. Transcranial Alternating Current Stimulation (tACS)
12.7.3. Transcranial Pulsed Current Stimulation (tPCS)
12.7.4. Transcranial Random Noise Stimulation (tRNS)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transcranial Electrical Stimulators Demand Share, 2019-2026
13. Middle East & Africa Transcranial Electrical Stimulators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transcranial Electrical Stimulators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transcranial Electrical Stimulators Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transcranial Electrical Stimulators Market Size and Volume Forecast by Type
13.7.1. Transcranial Direct Current Stimulation (tDCS)
13.7.2. Transcranial Alternating Current Stimulation (tACS)
13.7.3. Transcranial Pulsed Current Stimulation (tPCS)
13.7.4. Transcranial Random Noise Stimulation (tRNS)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transcranial Electrical Stimulators Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transcranial Electrical Stimulators Market: Market Share Analysis
14.2. Transcranial Electrical Stimulators Distributors and Customers
14.3. Transcranial Electrical Stimulators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Magstim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. NeuroCare Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Neuroelectrics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Newronika
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Rogue Resolutions
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Soterix Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
